🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

What's Going On With Hologic Shares Today?

Published 09/01/2023, 17:38
Updated 09/01/2023, 18:40
© Reuters.  What's Going On With Hologic Shares Today?
HOLX
-
H1OL34
-

Benzinga - Hologic, Inc. (NASDAQ: HOLX) shares are trading higher today after the company reported preliminary first-quarter revenue results.

What happened: Hologic on Sunday announced that the company expects to report revenues of approximately $1.074 billion for the first quarter of 2023. These expected results are higher than the previous revenue guidance range of $940 to $990 million.

Favorable revenue estimates are driven by double-digit organic currency growth numbers, including:

  • 15.8% in Diagnostics ex-COVID
  • 24.5% in Molecular Diagnostics ex-COVID
  • 14.7% in Surgical
Steve MacMillan, Hologic’s Chairman, CEO, and President states, “Our preliminary revenue results once again showcase the strength of our franchises, with more growth drivers in each, powering Hologic in fiscal 2023.”

Hologic manufactures proprietary products for the healthcare needs of women, including diagnostics, breast health, surgical, and skeletal health.

According to data from Benzinga Pro, Hologic Inc. shares were up 3.91% at $80.87 at the time of publication. It has a 52-week high of $80.49, and a 52-week low of $59.78.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.